CORRECTION OF THE METABOLIC DEFECT IN PROPIONIC ACIDEMIA FIBROBLASTS BY MICROINJECTION OF A FULL-LENGTH CDNA OR RNA TRANSCRIPT ENCODING THEPROPIONYL-COA CARBOXYLASE BETA-SUBUNIT
Am. Lamhonwah et al., CORRECTION OF THE METABOLIC DEFECT IN PROPIONIC ACIDEMIA FIBROBLASTS BY MICROINJECTION OF A FULL-LENGTH CDNA OR RNA TRANSCRIPT ENCODING THEPROPIONYL-COA CARBOXYLASE BETA-SUBUNIT, Genomics, 19(3), 1994, pp. 500-505
Propionyl-CoA carboxylase (PCC) is a mitochondrial, biotin-dependent e
nzyme, composed of an equal number of alpha and beta subunits, that fu
nctions in the catabolism of branched-chain amino acids and other meta
bolites. Mutations of the PCCA (alpha subunit) or PCCB (beta subunit)
gene cause the inherited metabolic disease, propionic acidemia. We rep
ort the cloning of a full-length cDNA encoding the beta subunit of hum
an PCC. The open reading frame encodes a pre-beta polypeptide of 539 a
mino acids (58,205 Da). The cDNA was introduced into the expression ve
ctor, pRc/CMV, and microinjected into the nucleus or, as ribotranscrip
ts, into the cytoplasm of fibroblast lines from patients with defects
of the beta subunit. The restoration of function was monitored by auto
radiography of PCC-dependent [C-14]- propionate incorporation into cel
lular protein. These results confirm the completeness of the clone and
demonstrate the capacity for beta subunits derived from the microinje
cted cDNA or RNA to be transported into mitochondria and assembled wit
h endogenously derived a subunits to form functional PCC. (C) 1994 Aca
demic Press, Inc.